| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Pierre-Édouard Fournier | Q21337923 |
| Hervé Richet | Q114421288 | ||
| P2860 | cites work | Comparative genomics of multidrug resistance in Acinetobacter baumannii | Q25256737 |
| DNA uptake in bacteria | Q28146170 | ||
| Acinetobacter baumannii in human body louse | Q28730739 | ||
| Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain. | Q31977163 | ||
| Acinetobacter bacteremia in Hong Kong: prospective study and review. | Q33535379 | ||
| Genetic variation: molecular mechanisms and impact on microbial evolution | Q33820587 | ||
| Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital | Q33967629 | ||
| Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. | Q33970757 | ||
| Molecular characterization of integrons in Acinetobacter baumannii: description of a hybrid class 2 integron | Q33980718 | ||
| Integration of foreign DNA during natural transformation of Acinetobacter sp. by homology-facilitated illegitimate recombination | Q34012308 | ||
| Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii | Q34109543 | ||
| Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii | Q34157184 | ||
| Physiological characterization of natural transformation in Acinetobacter calcoaceticus | Q34360734 | ||
| Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus | Q34454447 | ||
| AcinetobacterOutbreaks, 1977–2000 | Q35119005 | ||
| Multi-resistant Gram-negative bacilli: from epidemics to endemics | Q35177871 | ||
| Treatment of Acinetobacter spp infections | Q35183740 | ||
| Bacterial resistances to inorganic mercury salts and organomercurials | Q35225459 | ||
| Antimicrobial resistance of Acinetobacter spp. in Europe | Q35859069 | ||
| Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance | Q36598039 | ||
| Effect of desiccation on the ultrastructural appearances of Acinetobacter baumannii and Acinetobacter lwoffii | Q39603231 | ||
| Molecular characterization of integrons in epidemiologically unrelated clinical isolates of Acinetobacter baumannii from Italian hospitals reveals a limited diversity of gene cassette arrays | Q39657816 | ||
| Plasmid DNA profiles of Acinetobacter baumannii: clinical application in a complex endemic setting | Q40645334 | ||
| Hospital-acquired infections following the 1999 Marmara earthquake | Q42041112 | ||
| Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals | Q42167294 | ||
| Transposon-mediated multiple antibiotic resistance in Acinetobacter strains | Q42926845 | ||
| Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. | Q43961916 | ||
| Molecular characterization of metallo-beta-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla(VIM-2) gene cassettes | Q43988737 | ||
| Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study | Q44043080 | ||
| Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned | Q44045605 | ||
| Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit | Q44267375 | ||
| Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. | Q44417867 | ||
| Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. | Q44454728 | ||
| Characterization of transformation-deficient mutants of Acinetobacter calcoaceticus | Q44483527 | ||
| Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study | Q44609136 | ||
| Distribution of Acinetobacter species on skin of healthy humans | Q44759996 | ||
| Colistin efficacy in an experimental model of Acinetobacter baumannii endocarditis | Q44932019 | ||
| Amikacin and colistin for treatment of Acinetobacter baumannii meningitis | Q46507457 | ||
| Exceptional desiccation tolerance of Acinetobacter radioresistens | Q48768327 | ||
| Serological and molecular evidence of Rickettsia helvetica in Denmark. | Q50578806 | ||
| Epidemiological typing and prevalence of integrons in multiresistant Acinetobacter strains. | Q53668776 | ||
| Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. | Q53872643 | ||
| Prevalence and antimicrobial patterns of Acinetobacter baumannii on hands and nares of hospital personnel and patients: the iceberg phenomenon again. | Q53947167 | ||
| The natural transformation of the soil bacteria Pseudomonas stutzeri and Acinetobacter sp. by transgenic plant DNA strictly depends on homologous sequences in the recipient cells. | Q54021498 | ||
| Isolation of Acinetobacter spp. including A. baumannii from vegetables: implications for hospital-acquired infections. | Q54083016 | ||
| Characterization of class 1 integron resistance gene cassettes and the identification of a novel IS-like element in Acinetobacter baumannii | Q54775354 | ||
| Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain | Q57726411 | ||
| Risk factors, clinical features and outcome ofAcinetobacter bacteremia in adults | Q59187134 | ||
| Relevance of Digestive Tract Colonization in the Epidemiology of Nosocomial Infections Due to Multiresistant Acinetobacter baumannii | Q59245547 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| Acinetobacter baumannii | Q3241189 | ||
| P304 | page(s) | 692-699 | |
| P577 | publication date | 2006-01-26 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | The epidemiology and control of Acinetobacter baumannii in health care facilities | |
| P478 | volume | 42 |
| Q42583566 | 2-DE analysis indicates that Acinetobacter baumannii displays a robust and versatile metabolism |
| Q42375064 | A 6-year surveillance of antimicrobial resistance patterns of Acinetobacter baumannii bacteremia isolates from a tertiary care hospital in Saudi Arabia during 2005-2010. |
| Q48311635 | A Case of Community-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii in Korea. |
| Q57478236 | A Metagenomic Approach to Evaluating Surface Water Quality in Haiti |
| Q42111192 | A Novel Insertion Sequence, IS Aba10 , Inserted into IS Aba1 Adjacent to the bla OXA-23 Gene and Disrupting the Outer Membrane Protein Gene carO in Acinetobacter baumannii |
| Q41834260 | A case of fulminant community-acquired Acinetobacter baumannii pneumonia in Korea |
| Q36025864 | A crypt-specific core microbiota resides in the mouse colon |
| Q37036579 | A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain |
| Q91897355 | A multimodal intervention program to control a long-term Acinetobacter baumannii endemic in a tertiary care hospital |
| Q79197223 | A new category--healthcare-associated pneumonia: a good idea, but problems with its execution |
| Q36402290 | A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii |
| Q33742697 | A rapid and simple method for constructing stable mutants of Acinetobacter baumannii |
| Q36002338 | A. baumannii histone acetyl transferase Hpa2: optimization of homology modeling, analysis of protein-protein interaction and virtual screening |
| Q42132845 | AbuO, a TolC-like outer membrane protein of Acinetobacter baumannii, is involved in antimicrobial and oxidative stress resistance |
| Q39586230 | Acinetobacter Infections among Adult Patients in Qatar: A 2-Year Hospital-Based Study |
| Q89507355 | Acinetobacter baumannii Gastrointestinal Colonization Is Facilitated by Secretory IgA Which Is Reductively Dissociated by Bacterial Thioredoxin A |
| Q36052630 | Acinetobacter baumannii Genes Required for Bacterial Survival during Bloodstream Infection. |
| Q38696093 | Acinetobacter baumannii Lipopolysaccharide Influences Adipokine Expression in 3T3-L1 Adipocytes. |
| Q92190635 | Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus in long-term care facilities in eastern Taiwan |
| Q33971195 | Acinetobacter baumannii infection inhibits airway eosinophilia and lung pathology in a mouse model of allergic asthma |
| Q42255792 | Acinetobacter baumannii infections in a tertiary care hospital in Mexico over the past 13 years |
| Q21263068 | Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells |
| Q36364166 | Acinetobacter baumannii strains isolated from patients in intensive care units in Goiânia, Brazil: Molecular and drug susceptibility profiles |
| Q34207603 | Acinetobacter baumannii-associated skin and soft tissue infections: recognizing a broadening spectrum of disease |
| Q36664292 | Acinetobacter baumannii: An Emerging and Important Pathogen |
| Q37202840 | Acinetobacter baumannii: an emerging multidrug-resistant threat |
| Q26830893 | Acinetobacter baumannii: an emerging opportunistic pathogen |
| Q34795807 | Acinetobacter baumannii: emergence of a successful pathogen |
| Q54907069 | Acinetobacter baumannii: trends in antimicrobial resistance after relocation of an intensive care unit in tunisia. |
| Q36950581 | Acinetobacter infections: a growing threat for critically ill patients |
| Q37037407 | Acinetobacter pneumonia: a review. |
| Q31141383 | Acinetobacter septicus sp. nov. association with a nosocomial outbreak of bacteremia in a neonatal intensive care unit |
| Q53692299 | Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features. |
| Q28756257 | Acinetobacter spp. in gunshot injuries |
| Q40064641 | Acquisition and clearance of multidrug resistant Acinetobacter baumannii on healthy young adults concurrently burned in a dust explosion in Taiwan: the implication for antimicrobial stewardship |
| Q36744790 | Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii |
| Q64091015 | Acute intraperitoneal infection with a hypervirulent Acinetobacter baumannii isolate in mice |
| Q64963647 | Aging exacerbates mortality of Acinetobacter baumannii pneumonia and reduces the efficacies of antibiotics and vaccine. |
| Q42210264 | Analysis and forecast for multidrug-resistant Acinetobacter baumannii Infections among liver transplant recipients |
| Q97644667 | Antibiotic Susceptibility, Clonality, and Molecular Characterization of Carbapenem-Resistant Clinical Isolates of Acinetobacter baumannii from Washington DC |
| Q39865670 | Antibiotic resistance and carriage class 1 and 2 integrons in clinical isolates of Acinetobacter baumannii from Tehran, Iran. |
| Q64933565 | Antibiotic resistance profile and co-production of extended spectrum beta lactamases and AmpC in Acinetobacter spp. in a level 1 trauma center from India. |
| Q41368137 | Antimicrobial Susceptibility and Clonal Relation Between Acinetobacter baumannii Strains at a Tertiary Care Center in Turkey |
| Q28386039 | Antimicrobial activity of nanoemulsion in combination with cetylpyridinium chloride in multidrug-resistant Acinetobacter baumannii |
| Q27024893 | Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside |
| Q35757944 | Antimicrobial resistance pattern of Gram-negative bacilli isolated from patients at ICUs of Army hospitals in Iran. |
| Q36769763 | Association of Single Nucleotide Polymorphisms in Toll-like Receptors with Acinetobacter baumanii Infectionin a Chinese Population |
| Q41815193 | Attributable mortality of Acinetobacter baumannii: no longer a controversial issue |
| Q42050464 | Azithromycin attenuates lung inflammation in a mouse model of ventilator-associated pneumonia by multidrug-resistant Acinetobacter baumannii |
| Q53688834 | Bacteremia and meningitis caused by OXA-23-producing Acinetobacter baumannii - molecular characterization and susceptibility testing for alternative antibiotics. |
| Q26799576 | Bacterial Infections in Hematopoietic Stem Cell Transplant Recipients |
| Q28365026 | Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014 |
| Q35859953 | Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump |
| Q33755384 | Biofilm is a Major Virulence Determinant in Bacterial Colonization of Chronic Skin Ulcers Independently from the Multidrug Resistant Phenotype |
| Q30235064 | Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options |
| Q36913336 | Bloodstream infections in the Intensive Care Unit |
| Q34321442 | Carbapenem resistance and Acinetobacter baumannii in Senegal: the paradigm of a common phenomenon in natural reservoirs |
| Q33997664 | Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination |
| Q39830088 | Carbapenem-resistant isolates of Acinetobacter baumannii in a municipal wastewater treatment plant, Croatia, 2014. |
| Q97525858 | Cathelicidin-related Antimicrobial Peptide Contributes to Host Immune Responses Against Pulmonary Infection with Acinetobacter baumannii in Mice |
| Q41841445 | Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of bla(OXA-51-like) genes |
| Q42268636 | Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. |
| Q39038590 | Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges |
| Q37291374 | Clinical and economic burden of antimicrobial resistance. |
| Q86533675 | Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections |
| Q92546679 | Clinical practice guidelines for the provision of renal service in Hong Kong: Infection Control in Renal Service |
| Q34740954 | Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain |
| Q39257346 | Cloning and expression of quorum sensing N-acyl-homoserine synthase (LuxI) gene detected in Acinetobacter baumannii |
| Q88346828 | Cloning of ompA gene from Acinetobacter baumannii into the eukaryotic expression vector pBudCE4.1 as DNA vaccine |
| Q92533791 | Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia |
| Q41220559 | Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections |
| Q36911392 | Community-acquired Acinetobacter infections |
| Q41983181 | Comparative analysis of Acinetobacters: three genomes for three lifestyles |
| Q41364861 | Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii |
| Q36905255 | Comparative genomic analysis of rapid evolution of an extreme-drug-resistant Acinetobacter baumannii clone |
| Q40360761 | Comparison of 16S ribosomal RNA gene sequence analysis and conventional culture in the environmental survey of a hospital |
| Q36396208 | Comparison of genospecies and antimicrobial resistance profiles of isolates in the Acinetobacter calcoaceticus-Acinetobacter baumannii complex from various clinical specimens |
| Q40128845 | Comparison of in-house and commercial real time-PCR based carbapenemase gene detection methods in Enterobacteriaceae and non-fermenting gram-negative bacterial isolates |
| Q39377732 | Comparison of molecular typing methods for the analyses of Acinetobacter baumannii from ICU patients |
| Q37413428 | Comparison of risk factors for recovery of Acinetobacter baumannii during outbreaks at two Kentucky hospitals, 2006. |
| Q35530918 | Complete genome sequence of multidrug-resistant Acinetobacter baumannii strain 1656-2, which forms sturdy biofilm |
| Q47952651 | Conformational stability of OXA-51 β-lactamase explains its role in carbapenem resistance of Acinetobacter baumannii |
| Q84865948 | Control of an Acinetobacter [corrected] baumannii outbreak in a neonatal ICU without suspension of service: a devastating outbreak in Diyarbakir, Turkey |
| Q36220803 | Control of carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit of a teaching hospital in Southern Italy. |
| Q64279856 | Control of outbreak in the neonatal intensive care unit in Latvia: whole-genome sequencing powered investigation and closure of the ward |
| Q36543138 | Controlling multiple-drug-resistant organisms at the hospital level |
| Q39608636 | Costs and Mortality Associated With Multidrug-Resistant Healthcare-Associated Acinetobacter Infections |
| Q48203787 | Crystal structure of a UDP-GlcNAc epimerase for surface polysaccharide biosynthesis in Acinetobacter baumannii |
| Q46293492 | Defining the interaction of the protease CpaA with its type II secretion chaperone CpaB and its contribution to virulence in Acinetobacter species |
| Q91692721 | Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant Acinetobacter baumannii |
| Q57281753 | Desiccation tolerance in Acinetobacter baumannii is mediated by the two-component response regulator BfmR |
| Q92133057 | Detection of Antimicrobial Resistance Genes Associated with Carbapenem Resistance from the Whole-Genome Sequence of Acinetobacter baumannii Isolates from Malaysia |
| Q45796678 | Detection of antibiotic resistant Acinetobacter baumannii in various hospital environments: potential sources for transmission of Acinetobacter infections. |
| Q41922309 | Detection of class 1 integron in Acinetobacter baumannii isolates collected from nine hospitals in Turkey. |
| Q92665923 | Diagnosis of severe community-acquired pneumonia caused by Acinetobacter baumannii through next-generation sequencing: a case report |
| Q55378575 | Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality. |
| Q59113616 | Dioscorea bulbiferaMediated Synthesis of Novel AucoreAgshellNanoparticles with Potent Antibiofilm and Antileishmanial Activity |
| Q34487712 | Diversity and Clinical Impact of Acinetobacter baumannii Colonization and Infection at a Military Medical Center |
| Q34415986 | Diversity of Acinetobacter baumannii in four French military hospitals, as assessed by multiple locus variable number of tandem repeats analysis |
| Q41811434 | Draft Genome Sequences of Respiratory and Urinary Tract Isolates of Acinetobacter baumannii from the Same Patient |
| Q34601684 | Drug treatment for multidrug-resistant Acinetobacter baumannii infections. |
| Q28554305 | Dynamic Computational Model of Symptomatic Bacteremia to Inform Bacterial Separation Treatment Requirements |
| Q64061080 | Dynamics of a Sporadic Nosocomial Complex Population |
| Q41564506 | Effect of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) on killing Acinetobacter baumannii by colistin |
| Q41851622 | Effect of chlorine exposure on the survival and antibiotic gene expression of multidrug resistant Acinetobacter baumannii in water. |
| Q57179932 | Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumannii |
| Q43863487 | Emergence of 16s rRNA methylase-producing nosocomial Acinetobacter baumannii isolates in a university hospital in Bulgaria |
| Q35982095 | Emergence of multidrug-resistant Acinetobacter baumannii producing OXA-23 Carbapenemase in Qatar |
| Q35039125 | Epidemiological monitoring of nosocomial infections caused by acinetobacter baumannii |
| Q35811323 | Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria: Extended-Spectrum β-Lactamases and Beyond |
| Q43254058 | Epidemiology and impact of imipenem resistance in Acinetobacter baumannii |
| Q41339701 | Epidemiology of extensive drug resistant Acinetobacter baumannii (XDRAB) at Security Forces Hospital (SFH) in Kingdom of Saudi Arabia (KSA). |
| Q38722054 | Epidemiology of multidrug-resistant Acinetobacter baumannii strains in Iran: a systematic review and meta-analysis |
| Q92733416 | Essential Gene Clusters Involved in Copper Tolerance Identified in Acinetobacter baumannii Clinical and Environmental Isolates |
| Q90184306 | Evaluation of synergistic effect of tazobactam with meropenem and ciprofloxacin against multi-drug resistant Acinetobacter baumannii isolated from burn patients in Tehran |
| Q46587921 | Evaluation of the antimicrobial properties of an alcohol-free 2% chlorhexidine gluconate solution |
| Q48095816 | Evolution of the Quorum network and the mobilome (plasmids and bacteriophages) in clinical strains of Acinetobacter baumannii during a decade |
| Q43069244 | Extensively drug-resistant Acinetobacter baumannii |
| Q92358977 | Faucet aerators as a reservoir for Carbapenem-resistant Acinetobacter baumannii: a healthcare-associated infection outbreak in a neurosurgical intensive care unit |
| Q37345244 | Frequency, risk factors, and antibiogram of Acinetobacter species isolated from various clinical samples in a tertiary care hospital in Odisha, India |
| Q41117526 | Functional Exposed Amino Acids of BauA as Potential Immunogen Against Acinetobacter baumannii |
| Q43077769 | Fungal serotype-specific differences in bacterial-yeast interactions |
| Q37210393 | Genome Sequence of Jumbo Phage vB_AbaM_ME3 of Acinetobacter baumanni. |
| Q41925322 | Genome Sequences of Four Acinetobacter baumannii-A. calcoaceticus Complex Isolates from Combat-Related Infections Sustained in the Middle East |
| Q40475902 | Genomic Evolution of Two Acinetobacter baumannii Clinical Strains from ST-2 Clones Isolated in 2000 and 2010 (ST-2_clon_2000 and ST-2_clon_2010) |
| Q92981410 | Genomic analysis of antibiotic resistance for Acinetobacter baumannii in a critical care center |
| Q36095081 | Global challenge of multidrug-resistant Acinetobacter baumannii |
| Q33520358 | Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii |
| Q37544704 | Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii |
| Q39845137 | Gut colonization by multidrug-resistant and carbapenem-resistant Acinetobacter baumannii in neonates |
| Q89965236 | Heavy Metal Toxicity in Armed Conflicts Potentiates AMR in A. baumannii by Selecting for Antibiotic and Heavy Metal Co-resistance Mechanisms |
| Q90601171 | High Prevalence and Endemicity of Multidrug Resistant Acinetobacter spp. in Intensive Care Unit of a Tertiary Care Hospital, Varanasi, India |
| Q35843094 | High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update. |
| Q39396781 | High-touch surfaces: microbial neighbours at hand. |
| Q30429049 | Hospital epidemiology and infection control in acute-care settings |
| Q40668574 | Host resistance to intranasal Acinetobacter baumannii reinfection in mice |
| Q90176780 | IL-10 Protects Mice From the Lung Infection of Acinetobacter baumannii and Contributes to Bacterial Clearance by Regulating STAT3-Mediated MARCO Expression in Macrophages |
| Q28274696 | Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis |
| Q36295475 | Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America |
| Q36006835 | Identification of Acinetobacter Species Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry |
| Q28484155 | Identification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formation |
| Q41649171 | Identification of genus Acinetobacter: Standardization of in-house PCR and its comparison with conventional phenotypic methods |
| Q28237546 | Identification of novel regulatory small RNAs in Acinetobacter baumannii |
| Q35956049 | Identification of virulence factors and antibiotic resistance markers using bacterial genomics |
| Q36573679 | Immunoprotective Efficacy of Acinetobacter baumannii Outer Membrane Protein, FilF, Predicted In silico as a Potential Vaccine Candidate |
| Q56891434 | Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii |
| Q36298237 | Impact of empirical antimicrobial therapy on the outcome of critically ill patients with Acinetobacter bacteremia. |
| Q38461269 | Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes |
| Q33576059 | Impact of multidrug-resistant organisms on patients considered for lung transplantation |
| Q37358737 | In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates |
| Q40246727 | In vitro evaluation of the susceptibility of Acinetobacter baumannii isolates to antiseptics and disinfectants: comparison between clinical and environmental isolates |
| Q83310118 | In-silico modeling of a novel OXA-51 from β-lactam-resistant Acinetobacter baumannii and its interaction with various antibiotics |
| Q33892585 | Infections Caused by Acinetobacter baumannii in Recipients of Hematopoietic Stem Cell Transplantation |
| Q59793287 | Infections in patients with aplastic Anemia in Chiang Mai University |
| Q55432467 | Infectious complications in adult burn patients and antimicrobial resistance pattern of microorganisms isolated. |
| Q33606363 | Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design |
| Q89661671 | Integrative analysis of outer membrane vesicles proteomics and whole-cell transcriptome analysis of eravacycline induced Acinetobacter baumannii strains |
| Q46151080 | Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice |
| Q46919961 | Investigation of Acinetobacter baumannii resistance to carbapenems in Marseille hospitals, south of France: a transition from an epidemic to an endemic situation |
| Q36594556 | Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii |
| Q41382350 | Isolation and identification of Acinetobacter species with special reference to antibiotic resistance |
| Q40188170 | Ligand-Mediated Folding of the OmpA Periplasmic Domain from Acinetobacter baumannii |
| Q58797288 | Local Repressor AcrR Regulates AcrAB Efflux Pump Required for Biofilm Formation and Virulence in |
| Q41193639 | Long-term effectiveness of infection and antibiotic control programs on the transmission of carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex in central Taiwan. |
| Q37525173 | Lung Transplantation in a Multidrug-Resistant Gram-Negative Acinetobacter Baumannii-Colonized Patient: A Case Report |
| Q55378478 | Mechanism of Anti-bacterial Activity of Zinc Oxide Nanoparticle Against Carbapenem-Resistant Acinetobacter baumannii. |
| Q98202475 | Mechanisms Protecting Acinetobacter baumannii against Multiple Stresses Triggered by the Host Immune Response, Antibiotics and Outside-Host Environment |
| Q37645121 | Mentholation affects the cigarette microbiota by selecting for bacteria resistant to harsh environmental conditions and selecting against potential bacterial pathogens |
| Q34351565 | Microbial diversity similarities in periodontal pockets and atheromatous plaques of cardiovascular disease patients |
| Q50066616 | Misidentification of Acinetobacter baumannii as Alcaligenes faecalis by VITEK 2 System; Case Report |
| Q35823099 | Molecular Analysis of Bacterial Microbiota on Brazilian Currency Note Surfaces. |
| Q53701137 | Molecular Characterization and Antibiotic Susceptibility Pattern of Acinetobacter Baumannii Isolated in Intensive Care Unit Patients in Al-Hassa, Kingdom of Saudi Arabia. |
| Q28552411 | Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center |
| Q47134501 | Molecular characterization of Acinetobacter baumannii isolated from Iraqi hospital environment |
| Q37770434 | Mortality associated with Acinetobacter baumannii infections experienced by lung transplant recipients |
| Q88170947 | Most commensally bacterial strains in human milk of healthy mothers display multiple antibiotic resistance |
| Q33294109 | Multi-drug resistant Acinetobacter infections in critically injured Canadian forces soldiers |
| Q40083329 | Multi-drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex infection outbreak in dogs and cats in a veterinary hospital |
| Q35690304 | Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. |
| Q33711902 | Multidrug resistant Acinetobacter |
| Q33549724 | Multidrug resistant Acinetobacter baumannii: risk factors for appearance of imipenem resistant strains on patients formerly with susceptible strains |
| Q91451957 | Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages |
| Q44406518 | Multidrug-resistant Acinetobacter baumannii: eyes wide shut? |
| Q90280528 | Multidrug-resistant profile and prevalence of extended spectrum β-lactamase and carbapenemase production in fermentative Gram-negative bacilli recovered from patients and specimens referred to National Reference Laboratory, Addis Ababa, Ethiopia |
| Q64283677 | Multidrug-resistant septicemia in neonates: A study from a teaching hospital of Northern India |
| Q44294907 | NK1.1(+) cells regulate neutrophil migration in mice with Acinetobacter baumannii pneumonia |
| Q40391889 | NLRP3 inflammasome mediates interleukin-1β production in immune cells in response to Acinetobacter baumannii and contributes to pulmonary inflammation in mice. |
| Q40160686 | NLRP3 inflammasome pathway has a critical role in the host immunity against clinically relevant Acinetobacter baumannii pulmonary infection |
| Q58693503 | Nanodelivery strategies for the treatment of multidrug-resistant bacterial infections |
| Q44306863 | Natural history of colonization with gram-negative multidrug-resistant organisms among hospitalized patients |
| Q45357796 | Need for improved antimicrobial and infection control stewardship in Vietnamese intensive care units |
| Q36314004 | Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice |
| Q46242619 | Nod2 is required for the early innate immune clearance of Acinetobacter baumannii from the lungs. |
| Q40883429 | Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases |
| Q36261103 | Nosocomial Isolates and Their Drug Resistant Pattern in ICU Patients at National Institute of Neurological and Allied Sciences, Nepal |
| Q48471708 | Nosocomial meningitis caused by Acinetobacter baumannii: risk factors and their impact on patient outcomes and treatments |
| Q54504980 | Nosocomial outbreak of infection with multidrug-resistant Acinetobacter baumannii in a medical center in Taiwan. |
| Q43756833 | Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital |
| Q33820538 | Occupational transmission of Acinetobacter baumannii from a United States serviceman wounded in Iraq to a health care worker |
| Q38849558 | Occurrence of an environmental Acinetobacter baumannii strain similar to a clinical isolate in paleosol from Croatia |
| Q40439741 | Outbreak of Acinetobacter baumannii bacteremia related to contaminated morphine used for patient-controlled analgesia |
| Q30248524 | Outbreaks in Health Care Settings |
| Q35915919 | Outcomes of critically ill cancer patients with Acinetobacter baumannii infection |
| Q36135237 | Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets |
| Q43005297 | Positive predictive value of Leeds acinetobacter medium for environmental surveillance of Acinetobacter baumannii |
| Q53701548 | Potential targets for next generation anti-microbial glycoconjugate vaccines. |
| Q88256804 | Preliminary experience of tigecycline treatment in critically ill children with ventilator-associated pneumonia |
| Q90215276 | Preliminary experience with tigecycline treatment for severe infection in children |
| Q41515547 | Prevalence of Aminoglycoside Resistance Genes in Acinetobacter baumannii Isolates |
| Q36282516 | Prevalence of MDR pathogens of bacterial meningitis in Egypt and new synergistic antibiotic combinations |
| Q40586092 | Prevalence of Multidrug-Resistant Bacteria on Fresh Vegetables Collected from Farmers' Markets in Connecticut. |
| Q42577909 | Prevalence of PER and VEB Type Extended Spectrum Betalactamases among Multidrug Resistant Acinetobacter baumannii Isolates in North-West of Iran |
| Q43148730 | Prevalence of antibiotics resistance and OXA carbapenemases genes in multidrug-resistant Acinetobacter baumannii isolates in central Taiwan |
| Q34009785 | Prevalence of bla NDM, bla PER, bla VEB, bla IMP, and bla VIM Genes among Acinetobacter baumannii Isolated from Two Hospitals of Tehran, Iran |
| Q46670417 | Prevalence of infection by carbapenem-resistant Acinetobacter baumannii in Spain (1999-2005) |
| Q89976826 | Protein Aggregation is Associated with Acinetobacter baumannii Desiccation Tolerance |
| Q42279834 | Protracted outbreak of multidrug-resistant Acinetobacter baumannii after intercontinental transfer of colonized patients |
| Q51916220 | Pseudo-outbreak of Acinetobacter lwoffii infection in a tertiary care center in Thailand. |
| Q46658358 | Purification and partial characterization of novel penicillin V acylase from Acinetobacter sp. AP24 isolated from Loktak Lake, an Indo-Burma biodiversity hotspot |
| Q35646590 | Quantitative proteomic analysis of host--pathogen interactions: a study of Acinetobacter baumannii responses to host airways |
| Q37789338 | Quorum sensing inAcinetobacter: an emerging pathogen |
| Q43080975 | RNA-Mediated cis Regulation in Acinetobacter baumannii Modulates Stress-Induced Phenotypic Variation |
| Q64120082 | Rapid Replacement of Acinetobacter baumannii Strains Accompanied by Changes in Lipooligosaccharide Loci and Resistance Gene Repertoire |
| Q36804312 | Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology |
| Q27666903 | Rational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complex |
| Q37009600 | Resistant gram-negative bacilli: A neglected healthcare crisis? |
| Q40211312 | Risk factors associated with multi-drug-resistant Acinetobacter baumannii nosocomial infections at a tertiary care hospital in Makkah, Saudi Arabia - a matched case-control study. |
| Q37164962 | Risk factors associated with postcraniotomy meningitis: A retrospective study |
| Q36144309 | Risk factors for hospital-acquired antimicrobial-resistant infection caused by Acinetobacter baumannii |
| Q82470159 | Risk factors for infections caused by multidrug-resistant bacteria in patients with solid tumours |
| Q37099423 | Role of NADPH phagocyte oxidase in host defense against acute respiratory Acinetobacter baumannii infection in mice |
| Q34328536 | Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection |
| Q90611752 | Role of plasmid carrying bla NDM in mediating antibiotic resistance among Acinetobacter baumannii clinical isolates from Egypt |
| Q33914214 | Role of the BaeSR two-component system in the regulation of Acinetobacter baumannii adeAB genes and its correlation with tigecycline susceptibility |
| Q37128301 | Screening for Gram-negative bacteria: Impact of preanalytical parameters |
| Q59796343 | Sepsis in Intensive Care Unit Patients: Worldwide data from the ICON audit |
| Q36423689 | Sequential outbreaks of infections by distinct Acinetobacter baumannii strains in a public teaching hospital in Houston, Texas |
| Q51818859 | Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii. |
| Q28255390 | Severe infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumannii |
| Q92971747 | Study of the immunogenicity of outer membrane protein A (ompA) gene from Acinetobacter baumannii as DNA vaccine candidate in vivo |
| Q55109762 | Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation. |
| Q52718950 | Substrate specificities and efflux efficiencies of RND efflux pumps of Acinetobacter baumannii. |
| Q43095257 | Surveillance and correlation of antibiotic consumption and resistance of Acinetobacter baumannii complex in a tertiary care hospital in northeast China, 2003-2011. |
| Q37912231 | Surveillance and management of multidrug-resistant microorganisms |
| Q35784520 | Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii |
| Q41817951 | Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii |
| Q38842620 | Tackling Threats and Future Problems of Multidrug-Resistant Bacteria |
| Q40965515 | Task force on management and prevention of Acinetobacter baumannii infections in the ICU. |
| Q40313313 | The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells |
| Q36646787 | The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. |
| Q42428390 | The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor |
| Q88499092 | The Role of Environmental Contamination in the Transmission of Nosocomial Pathogens and Healthcare-Associated Infections |
| Q38928095 | The biological activities of cinnamon, geranium and lavender essential oils |
| Q36223107 | The first six years of surveillance in pediatric and neonatal intensive care units in Turkey |
| Q40178454 | The genome sequence of Acinetobacter baumannii isolated from a septicemic patient in a local hospital in Malaysia |
| Q40366980 | The impact of primer sets on detection of the gene encoding biofilm-associated protein (Bap) in Acinetobacter baumannii: in silico and in vitro analysis |
| Q91727770 | The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis |
| Q35916415 | The influence of biofilm formation and multidrug resistance on environmental survival of clinical and environmental isolates of Acinetobacter baumannii. |
| Q37099006 | Therapeutic options for Acinetobacter baumannii infections |
| Q38049332 | Therapeutic options for Acinetobacter baumannii infections: an update |
| Q40171479 | Therapy for wound infections after earthquakes requires inclusion of drugs targeting Gram-negative bacteria |
| Q92537980 | Thioredoxin Modulates Cell Surface Hydrophobicity in Acinetobacter baumannii |
| Q36501497 | Three-year review of bacteriological profile and antibiogram of burn wound isolates in Van, Turkey |
| Q61812394 | Treatment of severe ventriculitis caused by extensively drug-resistant by intraventricular lavage and administration of colistin |
| Q37058001 | Treatment options for multidrug-resistant Acinetobacter species |
| Q34995636 | Two methionine aminopeptidases from Acinetobacter baumannii are functional enzymes. |
| Q84694923 | Two sequential outbreaks caused by multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 or OXA-72 oxacillinase in an intensive care unit in France |
| Q56794116 | Update on bacterial pathogens: virulence and resistance |
| Q34168292 | Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections |
| Q42248142 | Use of a stainless steel washer platform to study Acinetobacter baumannii adhesion and biofilm formation on abiotic surfaces |
| Q36672233 | Use of adherence monitors as part of a team approach to control clonal spread of multidrug-resistant Acinetobacter baumannii in a research hospital |
| Q40207057 | Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection |
| Q36683476 | Virulence of Acinetobacter baumannii Exhibiting Phenotypic Heterogeneous Growth against Meropenem in a Murine Thigh Infection Model |
| Q92668226 | Whole-Genome-Sequence-Based Characterization of Extensively Drug-Resistant Acinetobacter baumannii Hospital Outbreak |
| Q28597168 | World-wide variation in incidence of Acinetobacter associated ventilator associated pneumonia: a meta-regression |
| Q64254637 | infection with bacteremia and pneumonia |
| Q37177941 | β -Lactamase-Producing Multidrug-Resistant Bacterial Pathogens from Tracheal Aspirates of Intensive Care Unit Patients at National Institute of Neurological and Allied Sciences, Nepal |
Search more.